Core Viewpoint - Aethlon Medical, Inc. is set to release its financial results for the fiscal first quarter ending June 30, 2025, on August 13, 2025, at 4:15 p.m. ET, followed by a conference call to discuss these results and recent corporate developments [1][2]. Financial Results Announcement - The financial results will be announced on August 13, 2025, at 4:15 p.m. ET [1]. - A conference call will take place on the same day at 4:30 p.m. ET to review the financial results and recent developments [2]. Conference Call Details - Interested parties can register for the conference call online, and registered participants will receive a dial-in number [2]. - For those without internet access, a toll-free number is available for participation [3]. Replay Information - A replay of the conference call will be available approximately one hour after the call and can be accessed until September 13, 2025 [4]. Product Overview - The Aethlon Hemopurifier is an investigational medical device designed to remove enveloped viruses and tumor-derived extracellular vesicles from circulation [4]. - The device utilizes a novel platform that combines plasma separation, size exclusion, and affinity binding to target pathogenic elements in biological fluids [6]. Regulatory Designation - The Hemopurifier has received U.S. Food and Drug Administration Breakthrough Device Designation for treating advanced or metastatic cancer and life-threatening viruses [5]. Company Background - Aethlon Medical, Inc. is a clinical-stage medical device company based in San Diego, California, focusing on oncology and infectious disease [6].
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025